Aurora Cannabis Reaffirms Q2 Growth Guidance on EU, UK Expansion
Image
Edmonton – September 18, 2026 -- Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB) reaffirmed its fiscal 2027 second-quarter guidance for sequential growth in net revenue and adjusted EBITDA, citing new EU-GMP capacity and expanding market share in Germany, Poland and the United Kingdom.
Safari Flower Company adds EU-GMP capacity after July certification
The Canadian medical cannabis producer said its recently acquired Safari Flower Company, which received EU-GMP certification in July, is expected to generate incremental net revenue and adjusted EBITDA in the coming quarters. The certification adds to Aurora's position as one of the world's largest indoor EU-GMP certified producers.